Status:
COMPLETED
OCT and Invasion in Cutaneous Skin Lesions
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Cutaneous Squamous Cell Carcinoma
Bowen's Disease
Eligibility:
All Genders
Brief Summary
The increasing incidence of actinic keratosis (AK), morbus Bowen (MB) and cutaneous squamous cell carcinoma (cSCC), the patients with often multiple lesions and the disadvantages of invasive diagnosti...
Eligibility Criteria
Inclusion
- Patients who are included in a previous study on OCT, with written informed consent to use their data regarding OCT.
- Patients who retrospectively had an OCT scan for their skin lesion
- With a histological confirmed actinic keratosis, bowens disease or cutaneous squamous cell carcinoma of the skin
- with a differential diagnosis of a invasive lesion (cutaneous squamous cell carcinoma) and a non-invasive lesion (bowens disease or actinic keratosis).
Exclusion
- patients who waived informed consent
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT06014697
Start Date
March 1 2023
End Date
August 1 2024
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center+
Maastricht, Netherlands